Clinical TrialsSearch results
Number of results: 596
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Completed
- Extension Study following the studies MT-1186-A03 or A04 to Evaluate the Safety of Oral Edaravone in Subjects with Amyotrophic Lateral Sclerosis (ALS)
- Amyotrophic Lateral Sclerosis
- Kazuoki Kondo
- 2022-10-07
Completed
- Safety Extension Study of Oral Edaravone Administered in Subjects With Amyotrophic Lateral Sclerosis (ALS)
- Amyotrophic Lateral Sclerosis
- Kondo Kazuoki
- 2020-12-24
Not yet recruiting
- In vivo PET Study of Synaptic Density and Mitochondrial Function in Anorexia Nervosa
- Anorexia nervosa
- Yamasue Hidenori
- 2024-07-25
Recruiting
- Development of new treatments for adult and chronic anorexia nervosa
- Anorexia Nervosa
- Hidenori Yamasue
- 2022-06-04
Other
- Observational cohort study of remission induction therapy in Japanese patients with ANCA-associated vasculitis
- Anti-neutrophil cytoplasmic antibody(ANCA) associated vasculitis
- Research Committe of Intractable Vasculitis Syndrome of the Ministry of Health, Labor and Welfare of Japan
- 2009-02-28
Completed
- Assessment and finalization of a stimulation electrode for trans-esophageal motor-evoked potential
- Aortic aneurysm, aortic dissection, aortic injury, etc.
- Shiiya Norihiko
- 2021-06-14
Recruiting
- Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
- APS, BP, BS, DM, IMNM, and ITP (Please refer to "Others" section for abbreviations)
- Hashimoto Akiko
- 2024-11-25
Recruiting
- Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
- APS, BP, BS, DM, IMNM, and ITP (Please refer to "Others" section for abbreviations)
- Hashimoto Akiko
- 2024-05-27
Other
- Randomized, double-blind, placebo-controlled study of AMG0001(HGF plasmid) for patients with arteriosclerosis obliterans
- Arteriosclerosis obliterans
- Anges MG, Inc.
- 2007-06-04
Other
- Novel Insight into Revascularization Strategy - Target region Oxygenation-based Endovascular treatment
- Atherosclerosis obliterans
- Inuzuka Kazunori
- 2020-09-10